MindMed Files Proxy Statement for June 12th Shareholder Meeting
Ticker: DFTX · Form: DEF 14A · Filed: Apr 23, 2025 · CIK: 1813814
| Field | Detail |
|---|---|
| Company | Mind Medicine (Mindmed) Inc. (DFTX) |
| Form Type | DEF 14A |
| Filed Date | Apr 23, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, shareholder-voting
TL;DR
MindMed's proxy statement is out for the 6/12 meeting - shareholders need to vote!
AI Summary
Mind Medicine (MindMed) Inc. filed its definitive proxy statement (DEF 14A) on April 23, 2025, for its annual meeting scheduled for June 12, 2025. The company, focused on medicinal chemicals and botanical products, is headquartered at One World Trade Center in New York. This filing outlines the information shareholders need to vote on company matters.
Why It Matters
This filing is crucial for shareholders as it details the agenda and proposals for the upcoming annual meeting, allowing them to make informed voting decisions on the company's future direction.
Risk Assessment
Risk Level: low — This is a routine proxy filing, providing information to shareholders for an upcoming meeting, and does not inherently introduce new financial or operational risks.
Key Numbers
- 001-40360 — SEC File Number (Identifies the company's filings with the SEC.)
- 25861688 — Film Number (Internal SEC processing number for the filing.)
Key Players & Entities
- Mind Medicine (MindMed) Inc. (company) — Registrant
- April 23, 2025 (date) — Filing Date
- June 12, 2025 (date) — Meeting Date
- One World Trade Center (location) — Company Address
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, or definitive proxy statement, is used by companies to solicit shareholder votes for their annual or special meetings, providing detailed information on the matters to be voted upon.
When is Mind Medicine (MindMed) Inc.'s annual meeting scheduled?
The annual meeting is scheduled for June 12, 2025, as indicated by the 'CONFORMED PERIOD OF REPORT' in the filing.
What is MindMed's primary business sector?
MindMed (MindMed) Inc. is classified under 'MEDICINAL CHEMICALS & BOTANICAL PRODUCTS' with the SIC code 2833.
Where is Mind Medicine (MindMed) Inc. located?
The company's business and mailing address is One World Trade Center, Suite 8500, New York, NY 10007.
Was there a fee required for this filing?
No fee was required for this filing, as indicated by the 'No fee required' checkbox being selected.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 23, 2025 regarding Mind Medicine (MindMed) Inc. (DFTX).